1. Home
  2. MMS vs GLSI Comparison

MMS vs GLSI Comparison

Compare MMS & GLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MMS
  • GLSI
  • Stock Information
  • Founded
  • MMS 1975
  • GLSI 2006
  • Country
  • MMS United States
  • GLSI United States
  • Employees
  • MMS N/A
  • GLSI N/A
  • Industry
  • MMS Business Services
  • GLSI Biotechnology: Pharmaceutical Preparations
  • Sector
  • MMS Consumer Discretionary
  • GLSI Health Care
  • Exchange
  • MMS Nasdaq
  • GLSI Nasdaq
  • Market Cap
  • MMS 3.9B
  • GLSI N/A
  • IPO Year
  • MMS 1997
  • GLSI 2020
  • Fundamental
  • Price
  • MMS $75.82
  • GLSI $9.66
  • Analyst Decision
  • MMS Buy
  • GLSI Strong Buy
  • Analyst Count
  • MMS 1
  • GLSI 1
  • Target Price
  • MMS $90.00
  • GLSI $39.00
  • AVG Volume (30 Days)
  • MMS 438.4K
  • GLSI 75.3K
  • Earning Date
  • MMS 05-08-2025
  • GLSI 05-19-2025
  • Dividend Yield
  • MMS 1.58%
  • GLSI N/A
  • EPS Growth
  • MMS 31.21
  • GLSI N/A
  • EPS
  • MMS 5.00
  • GLSI N/A
  • Revenue
  • MMS $5,395,260,000.00
  • GLSI N/A
  • Revenue This Year
  • MMS $0.90
  • GLSI N/A
  • Revenue Next Year
  • MMS $3.08
  • GLSI N/A
  • P/E Ratio
  • MMS $15.16
  • GLSI N/A
  • Revenue Growth
  • MMS 5.29
  • GLSI N/A
  • 52 Week Low
  • MMS $63.77
  • GLSI $8.06
  • 52 Week High
  • MMS $93.97
  • GLSI $18.75
  • Technical
  • Relative Strength Index (RSI)
  • MMS 74.17
  • GLSI 46.42
  • Support Level
  • MMS $65.67
  • GLSI $9.20
  • Resistance Level
  • MMS $67.65
  • GLSI $10.49
  • Average True Range (ATR)
  • MMS 1.79
  • GLSI 0.58
  • MACD
  • MMS 0.51
  • GLSI 0.04
  • Stochastic Oscillator
  • MMS 94.85
  • GLSI 42.99

About MMS Maximus Inc.

Maximus Inc designs, develops, and delivers programs, enabling people to access vital government services. It translates health and human services public policy into operating models that achieve outcomes for governments at scale. The company covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. The company operates through the following segments; U.S. Federal Services, U.S. Services, and Outside the U.S. A majority of its revenue is derived from the U.S. Federal Services segment which engages with various U.S. federal government agencies to deliver clinical services, maintenance services, and technology solutions.

Share on Social Networks: